Endari
Frontiers | In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System
Published human studies of L-glutamine for SCA | Download Table
Oral L-Glutamine Powder Lowers Frequency of Sickle Cell–Related Pain Episodes
NEJM on X: "Original Article and Quick Take video summary: A Phase 3 Trial of L-Glutamine in #SickleCell Disease https://t.co/AHPtjXdcRO https://t.co/l4h3UHz6jU" / X
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease | NEJM
Study shows L-Glutamine is effective and safe in fighting sickle cell pain attacks - School of Medicine News - Wayne State University
l-Glutamine for sickle cell anemia: more questions than answers - ScienceDirect
Pharmacy | Free Full-Text | Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
Therapeutic strategies for sickle cell disease: towards a multi-agent approach | Nature Reviews Drug Discovery
L-glutamine Supplement Can Lower Sickle Cell-Rated Pain
l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect
A New Step in the Treatment of Sickle Cell Disease | Biochemistry
Proposed Mechanism of Action for L-glutamine: GA: glutamine... | Download Scientific Diagram
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - ScienceDirect
l-Glutamine for sickle cell anemia: more questions than answers - ScienceDirect
Biomedicines | Free Full-Text | Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease
l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease | NEJM
L-glutamine Approved for Sickle Cell Disease
Understanding Sickle Cell Disease
Current Landscape in the Pharmacotherapy of Sickle Cell Disease (SCD) - Pharmaceutical Society of Jamaica
L-glutamine for sickle cell disease: Knight or pawn? - Alina Sadaf, Charles T Quinn, 2020
IJNS | Free Full-Text | Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease | NEJM
